Carl Zeiss Meditec News More News
Carl Zeiss Meditec Historical Prices
Date | Open | Close | Daily High | Daily Low |
---|
Price change over selected period:
0%
0
Carl Zeiss Meditec Analyst Opinions
- All
- Buy
- Hold
- Sell
Carl Zeiss Meditec Estimates* in EUR
2023 | 2024 | 2025 | 2026 | 2027 | |
---|---|---|---|---|---|
Revenue | 2,098 | 2,289 | 2,519 | 2,696 | 2,883 |
Dividend | 1.12 | 1.23 | 1.26 | 1.36 | - |
Dividend Yield (in %) | 0.81 % | 0.89 % | 0.91 % | 0.98 % | - |
EPS | 3.28 | 3.72 | 4.27 | 5.11 | 5.32 |
P/E Ratio | 42.04 | 37.13 | 32.29 | 27.00 | 25.94 |
EBIT | 418 | 475 | 544 | 613 | 656 |
EBITDA | 489 | 550 | 620 | 688 | 769 |
Net Profit | 291 | 327 | 374 | 438 | 472 |
Net Profit Adjusted | 296 | 334 | 385 | 439 | 474 |
Pre-Tax Profit | - | - | - | - | - |
Net Profit (Adjusted) | 422 | 479 | 542 | 611 | 677 |
EPS (Non-GAAP) ex. SOE | - | - | - | - | - |
EPS (GAAP) | 3.26 | 3.70 | 4.22 | 4.76 | 5.28 |
Gross Income | 1,225 | 1,340 | 1,483 | 1,653 | 1,863 |
Cash Flow from Investing | -76 | -85 | -83 | -83 | -110 |
Cash Flow from Operations | 332 | 387 | 437 | 496 | 519 |
Cash Flow from Financing | -112 | -111 | -97 | -115 | -149 |
Cash Flow per Share | 3.58 | 4.03 | 4.59 | - | - |
Free Cash Flow | 261 | 308 | 356 | 517 | 589 |
Free Cash Flow per Share | 2.76 | 3.09 | 3.53 | - | - |
Book Value per Share | 24.31 | 26.79 | 29.97 | - | - |
Net Debt | -617 | -750 | -831 | 271 | -1,029 |
Research & Development Exp. | 322 | 342 | 372 | 397 | 433 |
Capital Expenditure | 69 | 75 | 80 | 58 | 50 |
Selling, General & Admin. Exp. | 490 | 530 | 573 | 600 | - |
Shareholder’s Equity | 2,180 | 2,411 | 2,714 | 3,018 | 3,349 |
Total Assets | 2,961 | 3,197 | 3,477 | 3,872 | 4,206 |
Previous Quarter |
Current Quarter ending 03/31/23 |
Next Quarter ending 06/30/23 |
Current Year ending 09/30/23 |
Next Year ending 09/30/24 |
|
---|---|---|---|---|---|
Earnings Estimates | |||||
No. of Analysts | - | 1 | 1 | 11 | 11 |
Average Estimate | - | 0.785 EUR | 1.073 EUR | 3.282 EUR | 3.716 EUR |
Year Ago | - | 1.010 EUR | - | 3.290 EUR | 3.282 EUR |
Publish Date | - | 2/10/2023 | 5/9/2023 | - | - |
Revenue Estimates | |||||
No. of Analysts | - | 1 | 1 | 11 | 11 |
Average Estimate | - | 509 EUR | 564 EUR | 2,098 EUR | 2,289 EUR |
Year Ago | - | 445 EUR | - | 1,903 EUR | 2,098 EUR |
Publish Date | - | 2/10/2023 | 5/9/2023 | - | - |
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet
Carl Zeiss Meditec Dividend Calendar
Date | Name | Dividend | *yield | Currency |
---|---|---|---|---|
2022 | Carl Zeiss Meditec AG | 1.10 | 1.02 | EUR |
2021 | Carl Zeiss Meditec AG | 0.90 | 0.54 | EUR |
2020 | Carl Zeiss Meditec AG | 0.50 | 0.46 | EUR |
2019 | Carl Zeiss Meditec AG | 0.65 | 0.62 | EUR |
2018 | Carl Zeiss Meditec AG | 0.55 | 0.76 | EUR |
2017 | Carl Zeiss Meditec AG | 0.55 | 1.25 | EUR |
2016 | Carl Zeiss Meditec AG | 0.42 | 1.23 | EUR |
2015 | Carl Zeiss Meditec AG | 0.38 | 1.52 | EUR |
2014 | Carl Zeiss Meditec AG | 0.40 | 1.74 | EUR |
2013 | Carl Zeiss Meditec AG | 0.45 | 2.04 | EUR |
2012 | Carl Zeiss Meditec AG | 0.40 | 2.01 | EUR |
2011 | Carl Zeiss Meditec AG | 0.30 | 2.25 | EUR |
2010 | Carl Zeiss Meditec AG | 0.22 | 1.90 | EUR |
2009 | Carl Zeiss Meditec AG | 0.18 | 1.78 | EUR |
2009 | Carl Zeiss Meditec AG | 0.18 | 1.62 | EUR |
2008 | Carl Zeiss Meditec AG | 0.18 | 1.78 | EUR |
2007 | Carl Zeiss Meditec AG | 0.16 | 1.04 | EUR |
2006 | Carl Zeiss Meditec AG | 0.14 | 0.76 | EUR |
2005 | Carl Zeiss Meditec AG | 0.16 | 1.02 | EUR |
2004 | Carl Zeiss Meditec AG | - | - | EUR |
2003 | Carl Zeiss Meditec AG | - | - | EUR |
2002 | Carl Zeiss Meditec AG | - | - | EUR |
2001 | Carl Zeiss Meditec AG | - | - | EUR |
2000 | Carl Zeiss Meditec AG | - | - | EUR |
1999 | Carl Zeiss Meditec AG | - | - | EUR |
*Yield of the Respective Date
Carl Zeiss Meditec AG Calendar
Event | Estimate | Info | Date |
---|---|---|---|
Annual General Meeting | - | Annual General Meeting | 03/22/2023 |
Earnings Report | 1.073 EUR | Q2 2023 Earnings Release | 05/09/2023 |
Earnings Report | - | Q3 2023 Earnings Release | 08/04/2023 |
Earnings Report | - | Q4 2023 Earnings Release | 12/12/2023 |
Earnings Report | - | Q1 2024 Earnings Release | 02/09/2024 |
Earnings Report | - | Q2 2024 Earnings Release | 05/06/2024 |
Earnings Report | - | Q3 2024 Earnings Release | 08/09/2024 |
Earnings Report | - | Q4 2024 Earnings Release | 12/06/2024 |
Carl Zeiss Meditec AG Past Events
Event | Actual EPS | Info | Date |
---|---|---|---|
Earnings Report | 0.570 EUR | Q1 2023 Earnings Release | 02/10/2023 |
Shareholders' Meeting | - | - | 03/30/2022 |
Carl Zeiss Meditec Profile
Carl Zeiss Meditec AG engages in the development, manufacture and marketing of medical devices. It operates through the Ophthalmic Devices and Microsurgery business segments. The Ophthalmic Devices segment includes intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment offers surgical microscopes and visualization solutions for neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiotherapy. The company was founded on July 2002 and is headquartered in Jena, Germany.
Moody’s Daily Credit Risk Score
Carl Zeiss Meditec Shareholder
Owner | in % |
---|---|
Carl-Zeiss-Stiftung | 59.14 |
Freefloat | 40.86 |
American Funds Capital World Growth & Income Fund | 1.29 |
American Funds New Perspective Fund | 0.97 |
American Funds New World Fund | 0.88 |
Groupama Avenir EUR | 0.83 |
American Funds EuroPacific Growth Fund | 0.81 |
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.
Carl Zeiss Meditec Management
Name | Job |
---|---|
Markus Weber | Chairman-Management Board |
Karl Lamprecht | Chairman-Supervisory Board |
Justus Felix Wehmer | Chief Financial Officer |
Tania von der Goltz | Deputy Chairman-Supervisory Board |
Sebastian Frericks | Director-Investor Relations |
Rene Denner | Member-Supervisory Board |
Brigitte Koblizek | Member-Supervisory Board |
Jeffrey Marx | Member-Supervisory Board |
Peter Kameritsch | Member-Supervisory Board |
Christian Müller | Member-Supervisory Board |
Isabel de Paoli | Member-Supervisory Board |
Torsten Reitze | Member-Supervisory Board |